News

The findings suggest that healthcare systems must prioritise post-COVID-19 care, with a focus on identifying and managing autoimmune and autoinflammatory disorders.

Machine learning identifies key factors and predicts success in renal replacement therapy discontinuation for critically ill patients with acute kidney injury.

Recent data shows a significant increase in germline genetic testing for prostate cancer, with a notable rise in urologist involvement.

No difference in mortality found between indwelling pleural catheters and chemical pleurodesis for treating malignant pleural effusions.

VR/AR headsets could one day match desktops in diagnostic effectiveness, according to a recent study.

Patients with traumatic brain injury (TBI) and hypotension face doubled mortality odds, highlighting the need for precise blood pressure management in clinical practice.

Patients with late line relapsed/refractory multiple myeloma (RRMM) could benefit from repeat treatment with drugs their disease has previously been refractory to.

Glucagon-like peptide-1 receptor (GLP-1) agonists, particularly semaglutide, could be effective in reducing alcohol-related hospitalisations.